Increase in Serum Carbamazepine Concentrations after Acute Viral Hepatitis

MacKichan JJ . Carbamazepine. In: Taylor WJ Caviness MHD , eds. A textbook for the clinical application of therapeutic drug monitoring. Irving, TX: Abbott Laboratories, 1986: 211–24.

Rowland M . Elimination. In: Rowland M Tozer TN , eds. Clinical Pharmacokinetics. Concepts and applications. 2nd ed. Philadelphia: Lea and Febiger. 1989: 177–93.

Williams RL . Drug administration in hepatic disease. N Engl J Med 1983:309: 1616–22.

Hooper WD Dubetz DK Bochner F Cotter LM Smith GA Eadie MJ Plasma protein binding of carbamazepine. Clin Pharmacol Ther 1975;17:433–40.

Matsuo F Bergen D Faught E Messenheimer JA Dren AT Rudd GD Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284–91.

Eriksson AS Hoppu K Nergardh A Boreus L . Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia 1996;37: 769–73.

Bond S . Clinical relevance of the effect of hepatic disease on drug disposition. Am J Hosp Pharm 1978;35: 406–14.

Blaschke TF . Protein binding and kinetics of drugs in liver diseases. Clin Pharmacokinet 1977;2: 32–44.